iData Insights

Targovax AS - Product Pipeline Review – 2015 Is Released

Press Release   •   Feb 10, 2016 13:16 IST

This report provides comprehensive information on the current therapeutic developmental pipeline of Targovax ASs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Targovax AS including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Targovax ASs human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Targovax ASs pipeline products Reasons to buy - Evaluate Targovax ASs strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Targovax AS in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Targovax ASs R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Targovax AS and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Targovax AS - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Targovax AS and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues

Browse Complete Report with TOC http://www.idatainsights.com/reports-landing-page.php?id=179161/targovax-as-product-pipeline-review-2015

To Get Sample Copy of Report visit http://www.idatainsights.com/reports-landing-page.php?id=179161/targovax-as-product-pipeline-review-2015

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Targovax AS Snapshot 5

Targovax AS Overview 5

Key Information 5

Key Facts 5

Targovax AS - Research and Development Overview 6

Key Therapeutic Areas 6

Targovax AS - Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products - Monotherapy 9

Targovax AS - Pipeline Products Glance 10

Targovax AS - Clinical Stage Pipeline Products 10

Phase II Products/Combination Treatment Modalities 10

Phase I Products/Combination Treatment Modalities 11

Targovax AS - Early Stage Pipeline Products 12

Preclinical Products/Combination Treatment Modalities 12

Discovery Products/Combination Treatment Modalities 13

Targovax AS - Drug Profiles 14

TG-01 14

Product Description 14

Mechanism of Action 14

R&D Progress 14

ONCOS-102 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

ONCOS-402 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

TG-02 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

TG-03 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

ONCOS-802 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

ONCOS-902 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

Targovax AS - Pipeline Analysis 23

Targovax AS - Pipeline Products by Target 23

Targovax AS - Pipeline Products by Route of Administration 24

Targovax AS - Pipeline Products by Molecule Type 25

Targovax AS - Pipeline Products by Mechanism of Action 26

Targovax AS - Recent Pipeline Updates 27

Targovax AS - Dormant Projects 29

Targovax AS - Locations And Subsidiaries 30

Head Office 30

Other Locations & Subsidiaries 30

Appendix 31

Methodology 31

Coverage 31

Secondary Research 31

Primary Research 31

Expert Panel Validation 31

Contact Us 31

Disclaimer 32" width="80" height="40" />Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Targovax AS Snapshot 5

Targovax AS Overview 5

Key Information 5

Key Facts 5

Targovax AS - Research and Development Overview 6

Key Therapeutic Areas 6

Targovax AS - Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products - Monotherapy 9

Targovax AS - Pipeline Products Glance 10

Targovax AS - Clinical Stage Pipeline Products 10

Phase II Products/Combination Treatment Modalities 10

Phase I Products/Combination Treatment Modalities 11

Targovax AS - Early Stage Pipeline Products 12

Preclinical Products/Combination Treatment Modalities 12

Discovery Products/Combination Treatment Modalities 13

Targovax AS - Drug Profiles 14

TG-01 14

Product Description 14

Mechanism of Action 14

R&D Progress 14

ONCOS-102 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

ONCOS-402 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

TG-02 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

TG-03 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

ONCOS-802 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

ONCOS-902 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

Targovax AS - Pipeline Analysis 23

Targovax AS - Pipeline Products by Target 23

Targovax AS - Pipeline Products by Route of Administration 24

Targovax AS - Pipeline Products by Molecule Type 25

Targovax AS - Pipeline Products by Mechanism of Action 26

Targovax AS - Recent Pipeline Updates 27

Targovax AS - Dormant Projects 29

Targovax AS - Locations And Subsidiaries 30

Head Office 30

Other Locations & Subsidiaries 30

Appendix 31

Methodology 31

Coverage 31

Secondary Research 31

Primary Research 31

Expert Panel Validation 31

Contact Us 31

Disclaimer 32

Read More http://www.idatainsights.com/reports-landing-page.php?id=179161/targovax-as-product-pipeline-review-2015

About Us:

iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research information aggregator and marketing research consulting firm. We conduct both primary and secondary research. Our work does not end with research it is also involved in distributing reports for different companies . We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that will make a difference to their bottom line.

ContactUs:
iData Insights

Tel: 1-866-237-2965

Web: http://www.idatainsights.com
Email: info@idatainsights.com

AboutiData Insights

We work around the clock until our clients are completely satisfied with their promised results. It is our mission to provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our promise to provide results that are essential to the success of your company. We believe that by doing so, we will earn the trust of our clients for future project.